EMANUELLA CURTIS: Open Payments
NPI 1528663846 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 47 payments from 19 companies in 2025. Trend: 2023 $1,079 · 2024 $1,291 · 2025 $1,046
Food & beverage: $1,046
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 7 | $186 |
| Novo Nordisk Inc | 7 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $86 |
| Madrigal Pharmaceuticals | 3 | $81 |
| Lilly USA, LLC | 5 | $76 |
| Sequel Med Tech, LLC | 3 | $75 |
| Astellas Pharma US Inc | 4 | $73 |
| Insulet Corporation | 3 | $71 |
| PFIZER INC. | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Ozempic, Kerendia, REZDIFFRA, MOUNJARO, TWIIST, Veozah, Omnipod.
Industry payments across FL — which companies pay providers there.
